Gilead Sciences’ Trodelvy did not meet the main overall survival goal of its confirmatory Phase 3 test. The antibody drug conjugate was awarded accelerated approval for advanced urothelial carcinoma in 2021. The post Gilead Sciences Voluntarily Pulls Drug for Bladder Cancer After Trial Failure appeared first on MedCity News.
This technological shift not only boosts efficiency and profitability for pharmaceutical companies but also speeds up the delivery of innovative therapies to patients. The post Overcoming Pharma’s Major Pain Points and Pitfalls With AI appeared first on MedCity News.
Organizations are delivering digital experiences and content to HCPs on a much larger scale than was previously possible. Integrating digital tools will advance things even further and help marketers and MLR teams maintain brand consistency and ensure compliance across digital and content operations. The post Unify Digital Publishing with MLR Review to Speed Compliant Content…
Startups will take part in four different competitions at HLTH. There will also be plenty of opportunities to network. The post Which Startups Will Present at HLTH? appeared first on MedCity News.
CVS Health is reportedly exploring a breakup. But some experts aren’t sure if this is a good idea. The post Should CVS Health Break Up? appeared first on MedCity News.
Experts from BRG recently discussed the two presidential candidates’ stances on key healthcare issues, including drug pricing, Medicaid and AI. The post Where Trump & Harris Stand on Payers, AI, Drug Pricing and CMS appeared first on MedCity News.
Sanofi’s equity investment in the new Orano Med entity comes a month after the pharmaceutical giant struck a €100 million deal to license a clinical-stage radiopharmaceutical developed for neuroendocrine tumors. Orano Med develops targeted cancer therapies based on lead-212, an alpha-emitting isotope. The post Sanofi Puts Up €300M in New Targeted Radiation Cancer Therapy Pact…
Now is a great time for employers to consider the impact GI health has on workplace equity and take steps to ensure they’re doing what they can to create an equitable workplace The post Gut Health Can Be a Workplace Equity Issue. Here’s How HR Leaders Can Prevent That appeared first on MedCity News.
While federal healthcare programs focus their attention on ensuring healthcare resources exist for communities in need, HRSNs become critical drivers of whether individuals can actually access and benefit from these resources. The post Medicaid’s Health Equity Problem Starts and Ends with Health-Related Social Needs (HRSNs). Why Are They Being Overlooked? appeared first on MedCity News.
Oshi Health’s $60 million Series C funding round was led by Oak HC/FT and included participation from existing investors Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures and Takeda Digital Ventures. The post Oshi Health Secures $60M To Scale Virtual Digestive Care appeared first on MedCity News.